Aurinia Pharmaceuticals Inc (AUPH)
8.77
+0.53
(+6.43%)
USD |
NASDAQ |
Nov 21, 16:00
8.76
-0.01
(-0.11%)
Pre-Market: 08:18
Aurinia Pharmaceuticals Market Cap: 1.256B for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 21, 2024 | 1.256B |
| November 20, 2024 | 1.180B |
| November 19, 2024 | 1.164B |
| November 18, 2024 | 1.147B |
| November 15, 2024 | 1.163B |
| November 14, 2024 | 1.193B |
| November 13, 2024 | 1.186B |
| November 12, 2024 | 1.200B |
| November 11, 2024 | 1.216B |
| November 08, 2024 | 1.191B |
| November 07, 2024 | 1.194B |
| November 06, 2024 | 1.077B |
| November 05, 2024 | 1.048B |
| November 04, 2024 | 1.032B |
| November 01, 2024 | 1.048B |
| October 31, 2024 | 1.032B |
| October 30, 2024 | 1.053B |
| October 29, 2024 | 1.072B |
| October 28, 2024 | 1.036B |
| October 25, 2024 | 1.009B |
| October 24, 2024 | 1.007B |
| October 23, 2024 | 1.000B |
| October 22, 2024 | 1.012B |
| October 21, 2024 | 1.026B |
| October 18, 2024 | 1.006B |
| Date | Value |
|---|---|
| October 17, 2024 | 1.028B |
| October 16, 2024 | 1.028B |
| October 15, 2024 | 1.030B |
| October 14, 2024 | 1.019B |
| October 11, 2024 | 1.013B |
| October 10, 2024 | 998.90M |
| October 09, 2024 | 965.99M |
| October 08, 2024 | 976.00M |
| October 07, 2024 | 978.87M |
| October 04, 2024 | 1.019B |
| October 03, 2024 | 1.005B |
| October 02, 2024 | 1.019B |
| October 01, 2024 | 1.039B |
| September 30, 2024 | 1.049B |
| September 27, 2024 | 1.041B |
| September 26, 2024 | 1.024B |
| September 25, 2024 | 1.030B |
| September 24, 2024 | 1.004B |
| September 23, 2024 | 998.08M |
| September 20, 2024 | 1.030B |
| September 19, 2024 | 1.030B |
| September 18, 2024 | 1.012B |
| September 17, 2024 | 1.021B |
| September 16, 2024 | 1.020B |
| September 13, 2024 | 1.005B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
578.22M
Minimum
Nov 22 2019
4.286B
Maximum
Oct 29 2021
1.553B
Average
1.559B
Median
Market Cap Benchmarks
| Edesa Biotech Inc | 6.852M |
| Lexaria Bioscience Corp | 34.15M |
| Xenon Pharmaceuticals Inc | 3.034B |
| ESSA Pharma Inc | 78.09M |
| ImmunoPrecise Antibodies Ltd | 9.726M |
Market Cap Related Metrics
| PS Ratio | 5.746 |
| Price to Book Value | 3.236 |
| Price to Free Cash Flow | 44.73 |
| Price | 8.77 |
| Earnings Yield | -1.60% |